The evolutionarily conserved proto-oncogene c-myc is involved in both proliferation and differentiation processes of higher eukaryotic cells. We report here the identification and characterization of sequences homologous to c-myc in different Entamoeba species using a fragment of the mammalian c-myc gene as a probe. This probe hybridized with fragments of 3.5 and 3.4 kilobases (kb) in E. histolytica HindIII of EcoRI digested DNA. In E. invadens it recognized fragments of 3.1 and 2.8 kb, and in Laredo strain (reported as E. moshkovskii by Clark and Diamond in 1991) the probe hybridized with fragments of 17 kb. The c-myc probe identified transcripts of 3.3 and 1.5 kb in E. histolytica, transcripts of 1.8 and 1.3 kb in Laredo strain, and transcripts of 3.7, 1.8, 1.5 and 1.1 kb in E. invadens. Antibodies against a highly conserved region of the c-myc protein recognized in E. histolytica polypeptides of 35, 40, and 60 kDa. The expression of the 60 kDa polypeptide was temperature-inducible in Laredo strain. In E. invadens a 110 kDa strong band was detected by the antibodies. Surprisingly, E. invadens myc-like sequences and proteins showed greater homology to mammalian c-myc gene and proteins. Expression of proteins antigenically related to c-myc varied according to the cell cycle phase of E. histolytica. These proteins peaked during D, G1, and S phases and declined during G2.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF00932262 | DOI Listing |
Heliyon
August 2023
Department of Physical and Environmental Sciences, Texas A&M University-Corpus Christi, 6300 Ocean Drive, Corpus Christi, TX 78412, USA.
Two new developments of antibacterial agents, a series of benzofuran-triazine based compounds () were designed and synthesized. The derivatives were prepared through conventional chemical reactions and structurally characterized with FT-IR, H and C NMR techniques. The antibacterial activity of the synthesized derivatives was assessed against gram-positive bacterial strains and ) and gram-negative bacterial strains ( and ).
View Article and Find Full Text PDFAnaerobe
August 2023
Basurto University Hospital, Clinical Microbiology Service, Bilbao, Basque Country, Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Basque Country, Spain.
Bacteroides pyogenes is a Gram-negative obligate anaerobe, saccharolytic, non-motile, non-pigment-producing and non-spore-forming rod. Reports of human infections caused by B. pyogenes are scarce, with approximately 30 cases documented in scientific literature.
View Article and Find Full Text PDFRadiol Cardiothorac Imaging
February 2023
Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, LIB, Paris, France (M.L., J.L., K.B.V., M.G., A. Giron, A. Gallo, E.G., A.R., N.K.); Unité de Rythmologie, Institut de Cardiologie (M.L.), Radiologie Interventionnelle (P.C.), and Imagerie Cardiovasculaire et Thoracique (ICT) (A.R.), Sorbonne Université, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, 75013 Paris, France; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France (M.L., K.B.V., A. Giron, A. Gallo, E.G., A.R., N.K.); and Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.L.).
Purpose: To evaluate a cardiac MRI feature tracking (FT)-derived parameter that combines right ventricular (RV) longitudinal and radial motions in detecting arrhythmogenic right ventricular cardiomyopathy (ARVC).
Materials And Methods: Patients with ARVC ( = 47; median age, 46 [IQR, 30-52] years; 31 men) were compared with controls ( = 39; median age, 46 [IQR, 33-53] years; 23 men) and separated into two groups based on fulfillment of major structural 2020 International criteria. Cine data from 1.
Clin Rheumatol
March 2022
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de rhumatologie, Hôpital Saint-Antoine, Sorbonne Université, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France.
Hum Cell
May 2021
BioIntegrate, Lawrenceville, GA, 30043, USA.
COVID-19 has affected millions of people and put an unparalleled burden on healthcare systems as well as economies throughout the world. Currently, there is no decisive therapy for COVID-19 or related complications. The only hope to mitigate this pandemic is through vaccines.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!